Cooperative Agreement IDSEP240074
Award Date
9/12/24
Completion Date
11/30/35
Dollars Obligated
$62M
Awardee
Endo Usa, Inc. (D739PJVW5JF9)
Federal Grant Program
93.360
Assistance Type
Cooperative Agreement
Place of Performance
Pennsylvania, USA
Similar Awards
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...
The Defense Health Agency awarded Epicentrx Inc. a $385,536 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports the development and translation of a multimodal therapeutic agent and medical countermeasure for the treatment of military-related toxic exposures. The project will be conducted over a 3-year period from September 1, 2024 to August 31, 2027. The research aims to transform healthcare for military service members and...
This Cooperative Agreement, awarded by the Defense Health Agency, provides $568,275 in funding to Conserv Bioscience LIMITED, a foreign-owned for-profit organization, to develop an mRNA multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical...
This Cooperative Agreement awarded by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750) provides $4,603,542.00 to assess domestic production of pharmaceutical products for the military health system. The award, effective November 7, 2024 through November 6, 2026, supports a collaboration between the prime awardee, the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and...
This federal Project Grant award of $1,991,326.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) aimed at suppressing barrier antimicrobial defenses in the context of trauma. The 3-year grant, with a performance period from September 30, 2024 to September 29, 2027, will enable Bidmc, a prominent academic medical center in...
This Cooperative Agreement award of $41,075,241, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a highly synergistic center focused on developing end-to-end strategies for pandemic preparedness vaccine development targeting Bunyaviruses and Paramyxoviruses. The center brings together five research institutions with expertise in computational protein design, structure-based vaccine...
This federal Cooperative Agreement award, valued at $6,915,297.00, was granted by the Defense Advanced Research Projects Agency (DARPA) under the Research and Technology Development program (CFDA 12.910). The award supports the "Assured Microbial Preservation in Harsh or Remote Areas (AMPHORA)" program, which aims to develop fundamental technologies for assured microbial preservation in challenging environments. Key products and services to be delivered under this award include:...
The Cooperative Agreement award, funded by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750), is for the development of "SELF-DEPLOYING, INSTRUMENTED, SHAPE-MEMORY POLYMER ENDOTRACHEAL TUBES FOR NON- EXPERT, AUTONOMOUS EMERGENCY INTUBATION AND MONITORING OF THORACIC INJURIES IN BATTLEFIELD CONDITIONS". The $2,862,000.00 award, with a performance period from December 15, 2023 to December 14,...
This Cooperative Agreement award, valued at $415,769.00, was provided by the U.S. Army Research Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431). The award supports fundamental research by the University of Delaware to incorporate immune response into high-throughput bioprinted skin and lung models for the development of medical countermeasures. The research aims to expand scientific knowledge and understanding in areas critical to national...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $4,018,665 Cooperative Agreement under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program to the New Hampshire Department of Health & Human Services (NH DHHS). The award supports public health emergency preparedness and response capabilities across six key domains: incident management, jurisdictional recovery, biosurveillance,...